Abstract
In the fields of drug discovery and development, machine learning algorithms have been used for the development of novel drug candidates. The methods for designing drug targets and novel drug discovery now routinely combine machine learning and deep learning algorithms to enhance the efficiency, efficacy, and quality of developed outputs. The generation and incorporation of big data, through technologies such as high-throughput screening and high through-put computational analysis of databases used for both lead and target discovery, has increased the reliability of the machine learning and deep learning incorporated Algorithms. In this work, the applications that produce promising results and methods will be reviewed. The use of virtual screening and encompassing online information has also been highlighted in developing lead synthesis pathways.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
L. Patel, T. Shukla, X. Huang, D.W. Ussery, S. Wang, Machine learning methods in drug discovery. Molecules 25(22), 5277 (2020)
J. Fayyad, M.A. Jaradat, D. Gruyer, H. Najjaran, Deep learning sensor fusion for autonomous vehicle perception and localization: a review. Sensors 20(15), 4220 (2020)
J. Kowalewski, A. Ray, Predicting novel drugs for SARS-CoV-2 using machine learning from a> 10 million chemical space. Heliyon 6(8) (2020)
S. Mohanty, M.H.A. Rashid, M. Mridul, C. Mohanty, S. Swayamsiddha, Application of artificial intelligence in COVID-19 drug repurposing. Diabetes & Metabolic Syndrome: Clinical Research & Reviews (2020)
B. Ryu, D.S. Kim, A.M. DeLuca, R.M. Alani, Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PloS One 2(7) (2007)
Y.H. Feng, S.W. Zhang, J.Y. Shi, DPDDI: a deep predictor for drug-drug interactions. BMC Bioinformatics 21(1), 1–15 (2020)
F.R. Fields, S.D. Freed, K.E. Carothers, M.N. Hamid, D.E. Hammers, J.N. Ross, S.W. Lee, Novel antimicrobial peptide discovery using machine learning and biophysical selection of minimal bacteriocin domains. Drug Development Research 81(1), 43–51 (2020)
C.W. Coley, R. Barzilay, T.S. Jaakkola, W.H. Green, K.F. Jensen, Prediction of organic reaction outcomes using machine learning. ACS Central Science 3(5), 434–443 (2017)
Q. Yang, V. Sresht, P. Bolgar, X. Hou, J.L. Klug-McLeod, C.R. Butler, Molecular transformer unifies reaction prediction and retrosynthesis across pharma chemical space. Chem. Commun. 55(81), 12152–12155 (2019)
M. Ragoza, J. Hochuli, E. Idrobo, J. Sunseri, D.R. Koes, Protein-ligand scoring with convolutional neural networks. J. Chem. Inform. Model 57(4), 942–957 (2017)
P. Chang, J. Grinband, B.D. Weinberg, M. Bardis, M. Khy, G. Cadena, D. Chow, Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am. J. Neurorad. 39(7), 1201–1207 (2018)
A. Mencattini, D. Di Giuseppe, M.C. Comes, P. Casti, F. Corsi, F.R. Bertani, E. Martinelli, Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatments. Sci. Rep. 10(1), 1–11 (2020)
I.I. Baskin, D. Winkler, I.V. Tetko, A renaissance of neural networks in drug discovery. Expert Opinion Drug Disc. 11(8), 785–795 (2016)
F. Ghasemi, A. Mehridehnavi, A. Perez-Garrido, H. Perez-Sanchez, Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks. Drug Discov. Today 23(10), 1784–1790 (2018)
H. Chen, O. Engkvist, Y. Wang, M. Olivecrona, T. Blaschke, The rise of deep learning in drug discovery. Drug Disc. Today 23(6), 1241–1250 (2018)
M.H. Segler, T. Kogej, C. Tyrchan, M.P. Waller, Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Central Sci. 4(1), 120–131 (2018)
H.S. Chan, H. Shan, T. Dahoun, H. Vogel, S. Yuan, Advancing drug discovery via artificial intelligence. Trends Pharmacol. Sci. 40(8), 592–604 (2019)
Z. Zhou, X. Li, R.N. Zare, Optimizing chemical reactions with deep reinforcement learning. ACS Cent. Sci. 3(12), 1337–1344 (2017)
Yoshimasa & Takahashi, Identification of the dual action antihypertensive drugs using tfs-based support vector machines. Chem-Bio Inform. J. 9, 41–51 (2009)
G.P. Rossi, Dual ACE and NEP inhibitors: a review of the pharmacological properties of MDL 100,240. Cardiovasc. Drug Rev. 21(1), 51–66 (2003)
A. Korotcov, V. Tkachenko, D.P. Russo, S. Ekins, Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets. Molecul. Pharm. 14(12), 4462–4475 (2017)
Acknowledgements
We sincerely thank the reviewers and the Editor for their valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kushwah, V.S., Solanki, A., Votavat, B.M., Jain, A. (2022). Medication Revelation Utilizing Neural Network. In: Fernandes, S.L., Sharma, T.K. (eds) Artificial Intelligence in Industrial Applications. Learning and Analytics in Intelligent Systems, vol 25. Springer, Cham. https://doi.org/10.1007/978-3-030-85383-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-85383-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85382-2
Online ISBN: 978-3-030-85383-9
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)